The Effect of Carvelilol on Tumor Necrosis Factor-Α and Matrix Metalloproteinase in Rats after Acute Myocardial Infarction

李彬,廖玉华,程翔,周子华,葛洪霞,郭和平,逯保军
DOI: https://doi.org/10.3321/j.issn:1001-5213.2004.11.002
2004-01-01
Abstract:OBJECTIVE To observe the pharmacological effect of carvedilol on the expression of myocardium tumor necrosis factor-α (TNF-α) mRNA and protein and matrix metalloproteinase(MMP) mRNA and the activity in post-infarction rats. METHODS Rats surviving 24 h after AMI induced by left anterior descending branch ligation were randomized to carvedilol and control group compared with sham-operated group. Carvedilol group were given carvedilol 10 mg·(kg·d) -1.Control and sham-operated group were given saline 15 mL·(kg·d) -1.Observe the hemodynamic and ventricular remodeling index, the expression of myocardium TNF-α mRNA and protein and MMP-2, MMP-9 mRNA and the activity in all groups at the end of the fourth week. RESULTS The expression of myocardium TNF-α mRNA and protein, MMP-2 and MMP-9 mRNA and the activity were all increased in the AMI rats at 4 weeks compared with the sham-operated group. MMP-9 mRNA and activity were all positively correlated with TNF-α protein expression (r= 0.52, P 0.01)(r= 0.73,P 0.01).Treatment with carvedilol reduced the TNF-α mRNA and protein expression as well as MMP-2 and MMP-9 mRNA and the activity level and was associated with the amelioration of the hemodynamics and ventricular remodeling. CONCLUSION TNF-α and MMPs are involved in left ventricular remodeling after AMI. TNF-α may promote the gene expression and activity of MMP. The pharmacological effect of carvedilol of reduction in both myocardium TNF-α and MMP may be one of the beneficial effects of carvedilol on ventricular remodeling.
What problem does this paper attempt to address?